Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Obicetrapib safety analysis: Pooled phase 3 clinical trial experience.
Journal: American journal of preventive cardiology
Published: February 28, 2026
Cholesteryl ester transfer protein inhibition with obicetrapib is associated with attenuated decline in kidney function in patients at high cardiovascular risk: Post hoc pooled results from the BROADWAY and BROOKLYN trials.
Journal: American journal of preventive cardiology
Published: February 20, 2026
Showing 1-2 of 2
Last Updated: 09/26/2026